Advertisement

Topics

Samsung Bioepis contracts Catalent to help commercialize Benepali

05:43 EDT 19 Oct 2016 | in-PharmaTechnologis

Original Article: Samsung Bioepis contracts Catalent to help commercialize Benepali

NEXT ARTICLE

More From BioPortfolio on "Samsung Bioepis contracts Catalent to help commercialize Benepali"

Quick Search
Advertisement
 

Relevant Topic

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...